StockData
Dolby Laboratories, Inc. logo

Dolby Laboratories, Inc. (DLB) stock

DLBNYSEPatent Owners & LessorsFiscal year ends September 27
Financials through Q3 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 30, 2026Score 18/305% above fair value
$63.61−0.98 (-1.52%)

Close on Nov 13, 2026Market cap $5.96BP/E 27.1Yield 2.08%

Dolby Laboratories total assets

Total assets on the balance sheet at the end of each period.

Dolby Laboratories's total assets was $3.16B at Jun 26, 2026. For fiscal 2025 it was $3.23B, up 3.8% from the year before. Over ten years it grew 4.2% a year on average. The highest annual figure on record is $3.23B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Sep 26, 2025$3.23B+3.8%
FY2024Sep 27, 2024$3.11B+4.4%
FY2023Sep 29, 2023$2.98B+10.8%
FY2022Sep 30, 2022$2.69B-13.4%
FY2021Sep 24, 2021$3.11B+6.5%
FY2020Sep 25, 2020$2.92B+3.4%
FY2019Sep 27, 2019$2.82B-1.5%
FY2018Sep 28, 2018$2.87B+13.1%
FY2017Sep 29, 2017$2.53B+9.7%
FY2016Sep 30, 2016$2.31B+8.3%
FY2015Sep 25, 2015$2.13B+7.5%
FY2014Sep 26, 2014$1.98B+14.2%
FY2013Sep 27, 2013$1.74B-11.4%
FY2012Sep 28, 2012$1.96B+4.1%
FY2011Sep 30, 2011$1.88B+10.1%
FY2010Sep 24, 2010$1.71B+8.2%
FY2009Sep 25, 2009$1.58B–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 26, 2026$3.16B-1.2%
Q2 FY2026CQ1 2026Mar 27, 2026$3.25B+0.6%
Q1 FY2026CQ4 2025Dec 26, 2025$3.19B+1.1%
Q4 FY2025CQ3 2025Sep 26, 2025$3.23B+3.8%
Q3 FY2025CQ2 2025Jun 27, 2025$3.20B+7.5%
Q2 FY2025CQ1 2025Mar 28, 2025$3.23B+6.1%
Q1 FY2025CQ4 2024Dec 27, 2024$3.16B+7.6%
Q4 FY2024CQ3 2024Sep 27, 2024$3.11B+4.4%
Q3 FY2024CQ2 2024Jun 28, 2024$2.97B-1.1%
Q2 FY2024CQ1 2024Mar 29, 2024$3.04B+7.4%
Q1 FY2024CQ4 2023Dec 29, 2023$2.94B+6.8%
Q4 FY2023CQ3 2023Sep 29, 2023$2.98B+10.8%
Q3 FY2023CQ2 2023Jun 30, 2023$3.01B+3.0%
Q2 FY2023CQ1 2023Mar 31, 2023$2.84B-7.4%
Q1 FY2023CQ4 2022Dec 30, 2022$2.75B-11.5%
Q4 FY2022CQ3 2022Sep 30, 2022$2.69B-13.4%
Q3 FY2022CQ2 2022Jul 1, 2022$2.92B-6.9%
Q2 FY2022CQ1 2022Apr 1, 2022$3.06B-1.4%
Q1 FY2022CQ4 2021Dec 31, 2021$3.10B+0.3%
Q4 FY2021CQ3 2021Sep 24, 2021$3.11B+6.5%
Q3 FY2021CQ2 2021Jun 25, 2021$3.14B+8.0%
Q2 FY2021CQ1 2021Mar 26, 2021$3.11B+5.5%
Q1 FY2021CQ4 2020Dec 25, 2020$3.10B+7.0%
Q4 FY2020CQ3 2020Sep 25, 2020$2.92B+3.4%
Q3 FY2020CQ2 2020Jun 26, 2020$2.90B+3.3%
Q2 FY2020CQ1 2020Mar 27, 2020$2.94B+3.4%
Q1 FY2020CQ4 2019Dec 27, 2019$2.89B+2.5%
Q4 FY2019CQ3 2019Sep 27, 2019$2.82B-1.5%
Q3 FY2019CQ2 2019Jun 28, 2019$2.81B+5.2%
Q2 FY2019CQ1 2019Mar 29, 2019$2.85B+9.2%
Q1 FY2019CQ4 2018Dec 28, 2018$2.82B+12.3%
Q4 FY2018CQ3 2018Sep 28, 2018$2.87B+13.1%
Q3 FY2018CQ2 2018Jun 29, 2018$2.67B+8.0%
Q2 FY2018CQ1 2018Mar 30, 2018$2.61B+9.2%
Q1 FY2018CQ4 2017Dec 29, 2017$2.51B+7.9%
Q4 FY2017CQ3 2017Sep 29, 2017$2.53B+9.7%
Q3 FY2017CQ2 2017Jun 30, 2017$2.47B–
Q2 FY2017CQ1 2017Mar 31, 2017$2.39B–
Q1 FY2017CQ4 2016Dec 30, 2016$2.33B–
Q4 FY2016CQ3 2016Sep 30, 2016$2.31B–

More Dolby Laboratories figures

See a number that looks wrong?